India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 29 2025
0mins
Source: Reuters
Torrent Pharmaceuticals Acquires Stake in JB Chemicals: Torrent Pharmaceuticals will acquire a 46.39% controlling stake in JB Chemicals and Pharmaceuticals from KKR for approximately 119.17 billion rupees, with plans to merge the two companies to strengthen its presence in the Indian pharma market.
Financial Implications and Market Position: The acquisition values JB Pharma at 256.89 billion rupees, and both companies have reported increased profits, indicating strong demand for their pharmaceutical products in India, particularly in chronic illness treatments.
Analyst Views on KKR
Wall Street analysts forecast KKR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KKR is 159.67 USD with a low forecast of 145.00 USD and a high forecast of 176.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
9 Buy
0 Hold
0 Sell
Strong Buy
Current: 123.480
Low
145.00
Averages
159.67
High
176.00
Current: 123.480
Low
145.00
Averages
159.67
High
176.00
About KKR
KKR & Co. Inc. is a global investment firm that offers alternative asset management as well as capital markets and insurance solutions. The Company’s segments include Asset Management, Insurance and Strategic Holdings. Asset Management segment offers a range of investment management services to investment funds, vehicles and accounts and provides capital markets services to portfolio companies and third parties. Asset Management segment includes five business lines: Private Equity, Real Assets, Credit and Liquid Strategies, Capital Markets and Principal Activities. Insurance segment is operated by Global Atlantic, which is a United States retirement and life insurance company that provides a suite of protection, legacy and savings products and reinsurance solutions to clients across individual and institutional markets. Global Atlantic offers individuals fixed-rate annuities and others. Strategic Holdings segment represents its participation in its core private equity strategy.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
